http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013040873-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42d65fe799ad04010d5503ce24daae7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d913f8ff4a4f05ee8a5140f425c7c03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af8326044384bd115eaba11ef437fac1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11b7253b8fe1005cd254c5fb03a2e17d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-606
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-606
filingDate 2012-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc3412637f646ea03ad873b3a3e39da7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdd836a22812388c48db1c7542d252dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f606e1cc3cab03416d99c60295fde196
publicationDate 2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2013040873-A1
titleOfInvention Sustained and controlled release of micro-granule formulation for treating intestinal disease and preparation method thereof
abstract A sustained and controlled release of micro-granule formulation for treating intestinal diseases and preparation method thereof, the sustained and controlled release of micro-granule formulation comprising: a) a pellet core containing 5-aminosalicylic acid and adjuvant materials; b) an isolation layer containing one or more water soluble macromolecules and anti-sticking agent; c) a sustained release coating layer of sustained release materials; and d) an enteric coating layer of macromolecular enteric materials.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112315929-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114073720-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112315929-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112545997-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115192547-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111166729-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114073720-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113621182-A
priorityDate 2011-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010077908-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101496794-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226418074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128358759

Total number of triples: 40.